Media coverage
19
Media coverage
Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Business Wire Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213704132&p=1gw&v=1&x=p0Vsor1e5G6QZxsn27TDyQ Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy; Second IND Clearance for ATA3219 Following Non-Hodgkin's Lymphoma (NHL) and First in an Autoimmune Disease Indication; Initial Cli Media name/outlet Business Wire Country/Territory United States Date 29/02/24 Persons Rajani Dinavahi Title ATARA Biotherapeutics (ATRA) Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219 Media name/outlet Street Insider Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213728824&p=1gw&v=1&x=69wL9aX4Yr9OLvwkuvf7zA Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Morningstar.com Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213766619&p=1gw&v=1&x=iu8O5SsOT7yqXJgYInt6Uw Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet BioSpace Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53214261657&p=1gw&v=1&x=EQtf2jys6lBvaZA2-l2lsw Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet InvestorsObserver Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213719478&p=1gw&v=1&x=16h5y4v9Snk_NWRQgX8hsA Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet ADVFN UK Country/Territory United Kingdom Date 29/02/24 URL ct.moreover.com/?a=53213706324&p=1gw&v=1&x=Nj3XZCZyioy3dA7Pp7O8fw Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Yahoo! Finance Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213779249&p=1gw&v=1&x=8MTBwd6maMdlz4ngKt5tyQ Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Le Lezard.com Country/Territory Canada Date 29/02/24 URL ct.moreover.com/?a=53213703769&p=1gw&v=1&x=6zdYKY4HOEUv13ySH_gtlg Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet APNews.com Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213998232&p=1gw&v=1&x=HyPP8iLnRud2BPuXwVdUog Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Chase Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213713804&p=1gw&v=1&x=r8GJGGYwecPWD6KNmyPmrw Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet ADVFN US Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213732166&p=1gw&v=1&x=-0pnZI0o_4LZkz3faJfdRw Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet MarketScreener.com Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213777688&p=1gw&v=1&x=rvImdlMkEiniT7mmKhl_Ww Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Stockwatch Country/Territory Canada Date 29/02/24 URL ct.moreover.com/?a=53213782251&p=1gw&v=1&x=830dhJs-uXMz0_XvzhtPAA Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Pharmaceutical Daily Country/Territory Bosnia and Herzegovina Date 29/02/24 URL ct.moreover.com/?a=53215260736&p=1gw&v=1&x=ko7qLjhVso0SGIB7-eqb5w Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Acrofan Date 29/02/24 URL ct.moreover.com/?a=53213760696&p=1gw&v=1&x=dJY-mbIqdevIwp30ZBJmMQ Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Tyler Morning Telegraph Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213873918&p=1gw&v=1&x=uPq86rry262wX9IQ8euKPA Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet Valdosta Daily Times Country/Territory Georgia Date 29/02/24 URL ct.moreover.com/?a=53213961912&p=1gw&v=1&x=c9082psZJtbTBGRPYGx2BQ Persons Rajani Dinavahi Title Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy Media name/outlet WTNZ Country/Territory United States Date 29/02/24 URL ct.moreover.com/?a=53213839949&p=1gw&v=1&x=4h4z0D1hdnLQG0rrKUijkg Persons Rajani Dinavahi